Eva‐Lotte Lindstedt
Eva‐Lotte Lindstedt publishes mostly in Immunology, Physiology and Surgery, on topics such as Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Nitric Oxide and Endothelin Effects and Cholesterol and Lipid Metabolism.
- World rank
- #2,071,460 of 7,710,434 ranked researchers
- Rank in Sweden
- #26,786 of 71,437
- Works
- 31
- Citations
- 885
- Citations per work
- 28.5
What does Eva‐Lotte Lindstedt research?
Eva‐Lotte Lindstedt's work is mostly in Medicine (35%), Immunology and Microbiology (17%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1237.6%
- Health Sciences1135.1%
- Medicine1135.1%
- Life Sciences827.3%
- 1Immunology17% of their works
- 2Physiology10% of their works
- 3Surgery10% of their works
- 4Molecular Biology10% of their works
- 5Cardiology and Cardiovascular Medicine8% of their works
- 6Pharmacology6% of their works
Research topics
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Nitric Oxide and Endothelin Effects
- Cholesterol and Lipid Metabolism
- Eicosanoids and Hypertension Pharmacology
- Peroxisome Proliferator-Activated Receptors
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Hormonal Regulation and Hypertension
Which keywords describe Eva‐Lotte Lindstedt's research?
The keywords of their largest research topics: Inflammation, Metabolism, Reactive Oxygen Species, Atherosclerosis, NADPH Oxidases, Neutrophil Extracellular Traps, Cytochrome P450 and Hypertension.
- Primary Aldosteronism
- Drug Metabolism
- Peroxisome Proliferator-Activated Receptors
- Cyclooxygenase-2 Inhibitors
- Epoxyeicosatrienoic Acids
- Nitric Oxide
- Endothelial Dysfunction
- Hypertension
- Neutrophil Extracellular Traps
- Atherosclerosis
- Metabolism
- Inflammation
- Reactive Oxygen Species
- NADPH Oxidases
- Cytochrome P450
- Cholesterol
- LXR
- Arachidonic Acid
- Cancer
- PPARs
- Aldosterone
- Pharmacogenetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Inflammation285 topics
- Metabolism153 topics
- Reactive Oxygen Species152 topics
- Atherosclerosis122 topics
- NADPH Oxidases91 topic
- Neutrophil Extracellular Traps91 topic
- Cytochrome P45082 topics
- Hypertension82 topics
- Cholesterol61 topic
- Endothelial Dysfunction61 topic
- LXR61 topic
- Nitric Oxide61 topic
- Arachidonic Acid51 topic
- Epoxyeicosatrienoic Acids51 topic
- Cancer41 topic
- Cyclooxygenase-2 Inhibitors41 topic
- PPARs41 topic
- Peroxisome Proliferator-Activated Receptors41 topic
- Aldosterone31 topic
- Drug Metabolism31 topic
- Pharmacogenetics31 topic
- Primary Aldosteronism31 topic
Where does Eva‐Lotte Lindstedt work?
Eva‐Lotte Lindstedt's main affiliation in the publication record is AstraZeneca (Sweden), Sweden.
How many publications and citations does Eva‐Lotte Lindstedt have?
OpenAlex counts 31 works and 885 citations for Eva‐Lotte Lindstedt, an h-index of 12, ranking #2,071,460 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Eva‐Lotte Lindstedt. Posts are plain text and can be reported.